• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于正则化稀疏输入神经网络的多变量失效时间数据变量选择

Variable Selection for Multivariate Failure Time Data via Regularized Sparse-Input Neural Network.

作者信息

Luo Bin, Halabi Susan

机构信息

School of Data Science and Analytics, Kennesaw State University, Kennesaw, GA 30144, USA.

Department of Biostatistics and Bioinformatics, Duke University, Durham, NC 27708, USA.

出版信息

Bioengineering (Basel). 2025 May 31;12(6):596. doi: 10.3390/bioengineering12060596.

DOI:10.3390/bioengineering12060596
PMID:40564413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12189315/
Abstract

This study addresses the problem of simultaneous variable selection and model estimation in multivariate failure time data, a common challenge in clinical trials with multiple correlated time-to-event endpoints. We propose a unified framework that identifies predictors shared across outcomes, applicable to both low- and high-dimensional settings. For linear marginal hazard models, we develop a penalized pseudo-partial likelihood approach with a group LASSO-type penalty applied to the ℓ2 norms of coefficients corresponding to the same covariates across marginal hazard functions. To capture potential nonlinear effects, we further extend the approach to a sparse-input neural network model with structured group penalties on input-layer weights. Both methods are optimized using a composite gradient descent algorithm combining standard gradient steps with proximal updates. Simulation studies demonstrate that the proposed methods yield superior variable selection and predictive performance compared to traditional and outcome-specific approaches, while remaining robust to violations of the common predictor assumption. In an application to advanced prostate cancer data, the framework identifies both established clinical factors and potentially novel prognostic single-nucleotide polymorphisms for overall and progression-free survival. This work provides a flexible and robust tool for analyzing complex multivariate survival data, with potential utility in prognostic modeling and personalized medicine.

摘要

本研究解决了多变量失效时间数据中的同时变量选择和模型估计问题,这是具有多个相关事件发生时间终点的临床试验中的一个常见挑战。我们提出了一个统一的框架,该框架可识别不同结局之间共享的预测因子,适用于低维和高维设置。对于线性边际风险模型,我们开发了一种惩罚伪偏似然方法,对跨边际风险函数对应于相同协变量的系数的ℓ2范数应用组LASSO型惩罚。为了捕捉潜在的非线性效应,我们进一步将该方法扩展到具有输入层权重结构化组惩罚的稀疏输入神经网络模型。两种方法都使用结合标准梯度步长和近端更新的复合梯度下降算法进行优化。模拟研究表明,与传统方法和特定结局方法相比,所提出的方法具有更好的变量选择和预测性能,同时对违反共同预测因子假设具有鲁棒性。在一项对晚期前列腺癌数据的应用中,该框架识别出了用于总生存期和无进展生存期的既定临床因素以及潜在的新型预后单核苷酸多态性。这项工作为分析复杂的多变量生存数据提供了一个灵活且稳健的工具,在预后建模和个性化医疗中具有潜在应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/9ed8006eaa1b/bioengineering-12-00596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/23c322614b5e/bioengineering-12-00596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/33987cc59081/bioengineering-12-00596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/4db84b4f75af/bioengineering-12-00596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/9ed8006eaa1b/bioengineering-12-00596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/23c322614b5e/bioengineering-12-00596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/33987cc59081/bioengineering-12-00596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/4db84b4f75af/bioengineering-12-00596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c0/12189315/9ed8006eaa1b/bioengineering-12-00596-g004.jpg

相似文献

1
Variable Selection for Multivariate Failure Time Data via Regularized Sparse-Input Neural Network.基于正则化稀疏输入神经网络的多变量失效时间数据变量选择
Bioengineering (Basel). 2025 May 31;12(6):596. doi: 10.3390/bioengineering12060596.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Surgery for epilepsy.癫痫手术
Cochrane Database Syst Rev. 2015 Jul 1(7):CD010541. doi: 10.1002/14651858.CD010541.pub2.
5
Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.老年新诊断胶质母细胞瘤的治疗:一项网状Meta分析
Cochrane Database Syst Rev. 2020 Mar 23;3(3):CD013261. doi: 10.1002/14651858.CD013261.pub2.
6
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.抗癫痫药物单药治疗癫痫:一项个体参与者数据的网络荟萃分析。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD011412. doi: 10.1002/14651858.CD011412.pub4.
7
Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis.仑伐替尼联合帕博利珠单抗治疗未经治疗的晚期肾细胞癌:系统评价和成本效果分析。
Health Technol Assess. 2024 Aug;28(49):1-190. doi: 10.3310/TRRM4238.
8
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
9
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
10
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.

本文引用的文献

1
Enhanced MRI-based brain tumour classification with a novel Pix2pix generative adversarial network augmentation framework.基于增强磁共振成像的脑肿瘤分类与新型Pix2pix生成对抗网络增强框架
Brain Commun. 2024 Oct 24;6(6):fcae372. doi: 10.1093/braincomms/fcae372. eCollection 2024.
2
LassoNet: Neural Networks with Feature Sparsity.套索网络:具有特征稀疏性的神经网络。
Proc Mach Learn Res. 2021 Apr;130:10-18.
3
Development and validation of a multivariable prognostic model in de novo metastatic castrate sensitive prostate cancer.
初发转移性去势敏感性前列腺癌多变量预后模型的开发与验证
Prostate Cancer Prostatic Dis. 2023 Mar;26(1):119-125. doi: 10.1038/s41391-022-00560-3. Epub 2022 Jul 5.
4
Accelerating precision medicine in metastatic prostate cancer.加速转移性前列腺癌的精准医疗。
Nat Cancer. 2020 Nov;1(11):1041-1053. doi: 10.1038/s43018-020-00141-0. Epub 2020 Nov 17.
5
Genomic correlates of clinical outcome in advanced prostate cancer.晚期前列腺癌的临床结局的基因组相关性。
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi: 10.1073/pnas.1902651116. Epub 2019 May 6.
6
A primer on deep learning in genomics.深度学习在基因组学中的应用简介。
Nat Genet. 2019 Jan;51(1):12-18. doi: 10.1038/s41588-018-0295-5. Epub 2018 Nov 26.
7
DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network.DeepSurv:使用 Cox 比例风险深度神经网络的个性化治疗推荐系统。
BMC Med Res Methodol. 2018 Feb 26;18(1):24. doi: 10.1186/s12874-018-0482-1.
8
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.新辅助多西他赛和雄激素剥夺治疗高危前列腺癌的基因组学和转录组学治疗影响。
Clin Cancer Res. 2017 Nov 15;23(22):6802-6811. doi: 10.1158/1078-0432.CCR-17-1034. Epub 2017 Aug 25.
9
Deep learning for healthcare: review, opportunities and challenges.深度学习在医疗保健领域的应用:综述、机遇与挑战。
Brief Bioinform. 2018 Nov 27;19(6):1236-1246. doi: 10.1093/bib/bbx044.
10
Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.液体活检中雄激素受体的综合分析揭示了去势抵抗性前列腺癌中的新型 AR 结构变异和剪接变异表达模式。
Eur Urol. 2017 Aug;72(2):192-200. doi: 10.1016/j.eururo.2017.01.011. Epub 2017 Jan 16.